Both amyloid and tau pathologies may be required for substantial impairment of cholinergic synaptic plasticity and memory, and for continuous destruction of the projecting branches of the cholinergic nuclei in the basal forebrain [91, 92]. The gene discussed is MAPT; the disease is amyloidosis.